Category: Finance
Rise and Shine: Everything you need to know before the ASX opens
Good morning everyone, and welcome to 30 April, 2024 – an important date on the historical calendar for a number of reasons. Those include the tale [more…]
Airtasker delivers $2.5m free cash in Q3 FY24, ‘well ahead of plan’
Airtasker achieves positive free cash flow of $2.5 million in Q3 FY24, a $5.1 million improvement on the prior corresponding period (pcp) Positive group [more…]
Exploring the Future: ARK Invest’s Strategy in Tech Innovation
In an era marked by rapid technological advancements, ARK Invest’s chief futurist, Brett Winton, sheds light on the burgeoning sectors poised to reshape the economic [more…]
Closing Bell: ASX finds some bulldog as copper-gold pup Canterbury pops, just like we said it would
The ASX belts one out on Monday, up 0.8pc All 11 sectors are better for it Canterbury Resources grows by half The benchmark Aussie [more…]
Monsters of Rock: Cursed Ravensthorpe shuts AGAIN. Can these Japanese conglomerates bring WA nickel back to life?
Japanese conglomerates ramp up investment in WA nickel laterite just as Ravensthorpe operations shuts down (again) Lithium hopefuls LTR and LLL hit 80%+ completion [more…]
1000t of LCE on the books as Galan journeys towards Phase 1 lithium production at HMW
1000t of lithium concentrate in inventory at Galan’s flagship HMW project in Argentina Pond’s 1 and 2 continue evaporation, Pond 3 being filled, Pond 4 [more…]
CuFe lines up nine West Arunta niobium, rare earths targets for further testing
Geophysical review over CuFE’s exploration ground identifies nine targets that could host carbonatite intrusive niobium and REE mineralisation Target 001 defined by two ovoid pipe [more…]
Arizona Lithium achieves impressive steady-state 95pc recovery rates from Prairie pilot plant
>200,000L of brine for >13,500L lithium concentrate produced at Arizona Lithium’s Prairie project pilot plant A steady 95% lithium recovery rate achieved Impurity rejection of [more…]
AdAlta locks in $3.7m to speed up Phase II clinical trials, near-term partnerships
AdAlta has received an institutional investment of up to $3m from New Life Sciences LLC and $700,000 from Meurs Group The two investments will allow [more…]
ASX Small Caps Lunch Wrap: Monday morning rise proves life after inflation
From a lovely chilly Monday morning in Launceston, it appears stocks on the ASX have almost universally rebounded from a grim week – which, you’ll [more…]
